Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality

PartnershipProfhiloPositive

AI Analysis

Summary

Evolus announced a partnership with IBSA to develop and commercialize Profhilo in the United States, expanding its injectable portfolio into the skin quality market segment.

Importance:6/10

Sentiment:

0.60

PartnershipCommercializationInjectableSkin qualityPortfolio expansion

Related Companies

$EOLS

Read the original article

Published by yahoo_finance on July 8, 2026 1:00 PM

Read Original